Johnson & Johnson (JNJ) Other Working Capital Changes (2009 - 2026)
Johnson & Johnson recorded quarterly Other Working Capital Changes of -$349.0 million in Q1 2026, up 76.51% quarter-over-quarter from -$1.5 billion in Q4 2025, and down 126.5% year-over-year from $1.3 billion in Q1 2025.
Johnson & Johnson's Other Working Capital Changes history runs 18 years deep, the most recent figure standing at -$349.0 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 126.5% year-over-year to -$349.0 million; the TTM figure through Mar 2026 stood at $4.5 billion (up 60.81% YoY), while the FY2025 annual figure was $6.2 billion, up 459.17% from the prior year.
- Other Working Capital Changes came in at -$349.0 million for Q1 2026 at Johnson & Johnson, up from -$1.5 billion in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $4.9 billion in Q2 2025 to a low of -$3.2 billion in Q1 2024.
- A 5-year average of $532.1 million and a median of $229.0 million in 2023 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 1153.15% in 2024 and fell as far as 449.62% in 2024.
- Johnson & Johnson's Other Working Capital Changes stood at -$995.0 million in 2022, then jumped by 312.46% to $2.1 billion in 2023, then tumbled by 136.33% to -$768.0 million in 2024, then slumped by 93.49% to -$1.5 billion in 2025, then soared by 76.51% to -$349.0 million in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$349.0 million, -$1.5 billion, and $1.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | -349.00 Mn |
| Mar 29, 2026 | -349.00 Mn |
| Dec 28, 2025 | -1.49 Bn |
| Dec 28, 2025 | -1.49 Bn |
| Sep 28, 2025 | 1.46 Bn |
| Sep 28, 2025 | 1.46 Bn |
| Jun 29, 2025 | 4.88 Bn |
| Jun 29, 2025 | 4.88 Bn |
| Mar 30, 2025 | 1.32 Bn |
| Mar 30, 2025 | 1.32 Bn |
| Dec 29, 2024 | -768.00 Mn |
| Dec 29, 2024 | -768.00 Mn |
| Sep 29, 2024 | 2.78 Bn |
| Sep 29, 2024 | 2.78 Bn |
| Jun 30, 2024 | -532.00 Mn |
| Jun 30, 2024 | -532.00 Mn |
| Mar 31, 2024 | -3.20 Bn |
| Mar 31, 2024 | -3.20 Bn |
| Dec 31, 2023 | 2.11 Bn |
| Dec 31, 2023 | 2.11 Bn |
| Oct 1, 2023 | 222.00 Mn |
| Oct 1, 2023 | 222.00 Mn |
| Jul 2, 2023 | 229.00 Mn |
| Jul 2, 2023 | 229.00 Mn |
| Apr 2, 2023 | 915.00 Mn |
| Apr 2, 2023 | 915.00 Mn |
| Jan 1, 2023 | 1.40 Bn |
| Jan 1, 2023 | 1.40 Bn |
| Apr 3, 2022 | -995.00 Mn |
| Apr 3, 2022 | -995.00 Mn |
| Oct 3, 2021 | -667.00 Mn |
| Oct 3, 2021 | -667.00 Mn |
| Jul 4, 2021 | 1.11 Bn |
| Jul 4, 2021 | 1.11 Bn |
| Apr 4, 2021 | -2.52 Bn |
| Apr 4, 2021 | -2.52 Bn |
| Jan 3, 2021 | 1.72 Bn |
| Jan 3, 2021 | 1.72 Bn |
| Sep 27, 2020 | 935.00 Mn |
| Sep 27, 2020 | 935.00 Mn |
| Jun 28, 2020 | 1.32 Bn |
| Jun 28, 2020 | 1.32 Bn |
| Mar 29, 2020 | -271.00 Mn |
| Mar 29, 2020 | -271.00 Mn |
| Dec 29, 2019 | 973.00 Mn |
| Dec 29, 2019 | 973.00 Mn |
| Sep 29, 2019 | -781.00 Mn |
| Sep 29, 2019 | -781.00 Mn |
| Jun 30, 2019 | 374.00 Mn |
| Jun 30, 2019 | 374.00 Mn |
| Mar 31, 2019 | 488.00 Mn |
| Mar 31, 2019 | 488.00 Mn |
| Dec 30, 2018 | -629.00 Mn |
| Dec 30, 2018 | -629.00 Mn |
| Sep 30, 2018 | 637.00 Mn |
| Sep 30, 2018 | 637.00 Mn |
| Jul 1, 2018 | -640.00 Mn |
| Jul 1, 2018 | -640.00 Mn |
| Apr 1, 2018 | 907.00 Mn |
| Apr 1, 2018 | 907.00 Mn |
| Dec 31, 2017 | -144.00 Mn |
| Dec 31, 2017 | -144.00 Mn |
| Oct 1, 2017 | 14.00 Mn |
| Oct 1, 2017 | 14.00 Mn |
| Jul 2, 2017 | 117.00 Mn |
| Jul 2, 2017 | 117.00 Mn |
| Apr 2, 2017 | 424.00 Mn |
| Apr 2, 2017 | 424.00 Mn |
| Jan 1, 2017 | 1.52 Bn |
| Jan 1, 2017 | 1.52 Bn |
| Apr 3, 2016 | 802.00 Mn |
| Apr 3, 2016 | 802.00 Mn |
| Sep 27, 2015 | -384.00 Mn |
| Sep 27, 2015 | -384.00 Mn |
| Jun 28, 2015 | -1.16 Bn |
| Jun 28, 2015 | -1.16 Bn |
| Mar 29, 2015 | 562.00 Mn |
| Mar 29, 2015 | 562.00 Mn |
| Dec 28, 2014 | -370.00 Mn |
| Dec 28, 2014 | -370.00 Mn |
| Sep 28, 2014 | -636.00 Mn |
| Sep 28, 2014 | -636.00 Mn |
| Jun 29, 2014 | 412.00 Mn |
| Jun 29, 2014 | 412.00 Mn |
| Mar 30, 2014 | 152.00 Mn |
| Mar 30, 2014 | 152.00 Mn |
| Dec 29, 2013 | 1.35 Bn |
| Dec 29, 2013 | 1.35 Bn |
| Sep 29, 2013 | -34.00 Mn |
| Sep 29, 2013 | -34.00 Mn |
| Jun 30, 2013 | -226.00 Mn |
| Jun 30, 2013 | -226.00 Mn |
| Mar 31, 2013 | 608.00 Mn |
| Mar 31, 2013 | 608.00 Mn |
| Dec 30, 2012 | 474.00 Mn |
| Dec 30, 2012 | 474.00 Mn |
| Sep 30, 2012 | 278.00 Mn |
| Sep 30, 2012 | 278.00 Mn |
| Jul 1, 2012 | -242.00 Mn |
| Jul 1, 2012 | -242.00 Mn |
| Apr 1, 2012 | 754.00 Mn |
| Apr 1, 2012 | 754.00 Mn |
| Jan 1, 2012 | 1.48 Bn |
| Jan 1, 2012 | 1.48 Bn |
| Apr 3, 2011 | 970.00 Mn |
| Apr 3, 2011 | 970.00 Mn |
| Oct 3, 2010 | -394.00 Mn |
| Oct 3, 2010 | -394.00 Mn |
| Jul 4, 2010 | -384.00 Mn |
| Jul 4, 2010 | -384.00 Mn |
| Apr 4, 2010 | 1.09 Bn |
| Apr 4, 2010 | 1.09 Bn |
| Jan 3, 2010 | -1.24 Bn |
| Jan 3, 2010 | -1.24 Bn |
| Sep 27, 2009 | 7.00 Mn |
| Sep 27, 2009 | 7.00 Mn |
| Jun 28, 2009 | 67.00 Mn |
| Jun 28, 2009 | 67.00 Mn |
| Mar 29, 2009 | -39.00 Mn |
| Mar 29, 2009 | -39.00 Mn |